Milestone Pharmaceuticals Inc (MIST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 0 | 1,000 | 3,500 | 1,500 | 0 |
| Gross Profit | N/A | 1,000 | 3,500 | 1,500 | N/A |
| Operating Expenses | 16,436 | 16,502 | 17,259 | 16,530 | 16,806 |
| Operating Income | -16,436 | -15,502 | -13,759 | -15,030 | -16,806 |
| Interest Expense | 820 | 33 | 0 | 0 | 0 |
| Other Income | 1,213 | 585 | 582 | 474 | 158 |
| Pre-tax Income | -16,043 | -14,950 | -13,177 | -14,556 | -16,648 |
| Net Income Continuous | -16,043 | -14,950 | -13,177 | -14,556 | -16,648 |
| Net Income | $-16,043 | $-14,950 | $-13,177 | $-14,556 | $-16,648 |
| EPS Basic Total Ops | -0.37 | -0.35 | -0.32 | -0.34 | -0.39 |
| EPS Basic Continuous Ops | -0.37 | -0.35 | -0.31 | -0.34 | -0.39 |
| EPS Diluted Total Ops | -0.37 | -0.35 | -0.32 | -0.34 | -0.39 |
| EPS Diluted Continuous Ops | -0.37 | -0.35 | -0.31 | -0.34 | -0.39 |
| EBITDA(a) | $-16,412 | $-15,484 | $-13,744 | $-15,003 | $-16,782 |